Prime Medicine, Inc. (NASDAQ:PRME) is among the 12 Best Genomics Stocks to Invest In. Prime Medicine, Inc. (NASDAQ:PRME) stated on December 7, 2025, that the New England Journal of Medicine has ...

Two genetic innovations could address major welfare and productivity issues within the broiler and layer industries.

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

By one calculation, spending on AI accounted for 92 percent of America’s GDP growth in the first half of 2025. This year, a ...

Immense progress in gene editing, drug discovery and conservation are just some of the reasons to be cheerful about 2025 ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

CRISPR Therapeutics (NASDAQ: CRSP) soared a few years ago, climbing more than 200% from the start of 2020 through early 2021, ...

It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...

Launched in November 2019, the Chinese Academy of Sciences' Strategic Priority Research Program on "Precision Seed Design and Breeding" has identified a series of key genes linked to higher yields, ...

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...